Researchers have found flaws in some of the data that track and field officials used to formulate regulations for the complicated cases of Caster Semenya of South Africa, the two-time Olympic champion at 800 meters, and other female athletes with naturally elevated testosterone levels.

Three independent researchers said they believed the mistakes called into question the validity of a 2017 study commissioned by track and field’s world governing body, the International Federation of Athletics Associations, or I.A.A.F., according to interviews and a paper written by the researchers and provided to The New York Times.

The 2017 study was used to help devise regulations that could require some runners to undergo medical treatment to lower their hormone levels to remain eligible for the sport’s most prominent international competitions, like the Summer Games.

The researchers have called for a retraction of the study, published last year in the British Journal of Sports Medicine. The study served as an underpinning for rules, scheduled to be enacted in November, which would establish permitted testosterone levels for athletes participating in women’s events from 400 meters to the mile.